NASDAQ · Medical - Devices

Autonomix Medical, Inc. (AMIX) Stock

$3.14 +0.32% NASDAQ: AMIX Healthcare

Valuation

MetricValue
Price$3.14
Market Cap$1.71M
P/E Ratio-0.08
P/B Ratio0.61
P/S Ratio0.00
EPS (TTM)$-2.32
52-Week High$32.55
52-Week Low$2.44
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-267.73%
ROA-404.67%
ROCE-518.15%
Gross Margin0.00%
Operating Margin0.00%
Net Margin0.00%
Debt/Equity0.00
Current Ratio4.00

Annual Financials (USD)

Metric20222023202420252026
Revenue$0$0$0$0$0
Operating Profit$-14.0M$-2.0M$-12.0M$-12.0M$-17.0M
Net Profit$-13.0M$-2.0M$-15.0M$-11.0M$-17.0M
EPS$-286.98$-44.48$-343.78$-135.65$-48.64
Op Margin—————

Balance Sheet (USD)

Metric20222023202420252026
Total Assets$2.0M$1.0M$9.0M$10.0M$8.0M
Total Liabilities$0$0$2.0M$2.0M$2.0M
Cash$2.0M$1.0M$9.0M$9.0M$7.0M
Borrowings$0$0$1.0M$0$0

Latest News

Autonomix Medical Receives US Patent Covering Neural Sensing Technology for Overactive Bladder MT Newswires · Jul 15, 2026 Autonomix Medical Granted U.S. Patent for Overactive Bladder Diagnosis and Treatment Platform GlobeNewswire · Jul 15, 2026 Autonomix Medical Enters into $2.6 Million Warrant Inducement Priced At-the-Market Under Nasdaq Rules GlobeNewswire · Jul 14, 2026 Autonomix Medical Receives Canadian Patent for Neural Sensing Technology MT Newswires · Jul 13, 2026 Autonomix Medical Strengthens Global Intellectual Property Position with New Neural Sensing Patent Grant GlobeNewswire · Jul 13, 2026

Cash Flow (USD)

Metric20222023202420252026
Operating Cash Flow$0$-2.0M$-7.0M$-8.0M$-12.0M
Investing Cash Flow$0$0$0$0$0
Financing Cash Flow$0$0$-1.0M$-1.0M$8.0M
Net Cash Flow$2.0M$-1.0M$8.0M$1.0M$-2.0M
Free Cash Flow$0$-2.0M$-7.0M$-8.0M$-12.0M

Valuation & Return Ratios

MetricValue
PEG Ratio0.00
EV / EBITDA0.09
FCF Yield-625.06%
Quick Ratio4.85
Interest Coverage0.00
Return 1Y-82.80%
Return 3Y—
Return 5Y—

Ownership

Insiders Held4.11%
Institutions Held4.22%
Institutions Float Held4.40%
Institutional HolderSharesReport Date
Geode Capital Management, LLC8,3632026-03-31
Mariner, LLC2,5202026-03-31
UBS Group AG1,5952026-03-31
LPL Financial LLC1,4972026-03-31
Bank of Montreal /CAN/1,1902026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
AIMAIM ImmunoTech Inc. $0.18 +1.00% -0.05 $7.11M 0.00%
BBLGBone Biologics Corp $0.46 -1.83% -0.26 $833680 0.00%
DHAIDIH Holding US, Inc. $0.02 +0.00% 0.00 $41853 0.00%
FLGCFlora Growth Corp. $7.79 -32.14% -0.54 $4.23M 0.00%
HSCSHeartSciences Inc. $3.33 +9.54% -1.36 $7.19M 0.00%

About Autonomix Medical, Inc.

Autonomix Medical, Inc. is led by CEO Bradley Hauser, employs 5 people, headquartered in US, publicly traded since 2024.

Autonomix Medical, Inc. (AMIX) stock trades at $3.14 with a market capitalization of $1.71M. The stock is valued at a price-to-earnings (P/E) ratio of -0.08, price-to-book of 0.61, price-to-sales of 0.00. Over the past 52 weeks the stock has ranged between $2.44 and $32.55, and currently trades 90.4% below its 52-week high.

On profitability, Autonomix Medical, Inc. generates a return on equity (ROE) of -267.73%, return on capital employed of -518.15%, an operating margin of 0.00%, a net profit margin of 0.00%.

Related Healthcare Stocks

LLY Eli Lilly and Company $1175.60 +0.51% JNJ Johnson & Johnson $259.92 +1.34% ABBV AbbVie Inc. $276.17 +1.38% MRK Merck & Company, Inc. Common Stock (new) $146.13 +2.63% UNH UnitedHealth Group Incorporated Common Stock (DE) $382.39 +3.08% NVS Novartis AG $143.79 +0.47% AZN AstraZeneca PLC $159.37 +0.37% TMO Thermo Fisher Scientific Inc $659.63 +1.17% AMGN Amgen Inc. $417.07 +2.36% GILD Gilead Sciences, Inc. $150.92 +2.60% ABT Abbott Laboratories $99.12 +0.64% NVO Novo Nordisk A/S $38.42 +0.62%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides